摘要:
This invention is directed to compounds of the formula ##STR1## wherein X is a thiazine or thiazepine selected from ##STR2## These compounds possess angiotensin converting enzyme inhibition activity and are thus useful as hypotensive agents.
摘要:
A process for preparing 1,5-benzothiazepine derivatives of the formula: ##STR1## wherein Ar is a phenyl substituted with a lower alkoxy, R is a lower alkyl, R.sup.1 and R.sup.2 are each a lower alkyl, and Y is a lower alkylene, which have excellent coronary vasodilating and psychoneurotic activities and are useful particularly as a Ca.sup.++ -antagonistic coronary vasodilator.
摘要:
Cis or trans-1,5-benzothiazepine compounds represented by the formula (I): ##STR1## wherein R.sub.1 represents a hydrogen atom, a halogen atom, an alkyl group or an alkoxy group and R.sub.2 represents a hydrogen atom, an alkyl group or a hydroxyalkyl group and the pharmaceutically acceptable acid addition salts and quaternary ammonium salts thereof which exhibit anticholinergic activity and are useful as anti-ulcer, gastric secretion inhibiting and antispasmodic agents in mammals, and a process for preparing the same.
摘要:
This invention provides new compounds of formula I, ##STR1## wherein R.sub.1 and R.sub.2 are independently hydrogen, halogen, trifluoromethyl, lower alkoxy or lower alkyl,R.sub.3 is hydrogen, lower alkyl, lower hydroxyalkyl, or phenylalkyl of 7 to 10 carbon atoms, wherein the phenyl ring is unsubstituted or mono-substituted, or independently di-substituted, by halogen, lower alkyl, lower alkoxy, amino, lower alkylamino or di(lower alkyl)amino, andR.sub.4 is hydrogen, lower alkyl or lower hydroxyalkyl,Useful as anti-arrhythmics and anti-depressants.
摘要:
The present invention relates to cyclopropylmethyl amines substituted by a heterocyclic radical.More particularly the heterocyclic radical is a nitrogen containing ring with 5, 6 or 7 links interrupted by another hetero atom selected from the group consisting of oxygen, sulphur and imino--NH--The invention also relates to the acid addition salts thereof with physiologically compatible mineral or organic acids.The invention extends to the processes for making them and the intermediates produced hereto.The invention also includes the pharmaceutical compositions incorporating as active ingredient at least one compound of the invention with an inert carrier.The compounds have therapeutic utility namely on the cardio-vascular diseases and on the neuro-psychological disturbances.
摘要:
Novel benzothiazepines having the structure ##SPC1##The pharmaceutically acceptable salts thereof, the quaternary ammonium salts thereof, and the 1-oxide and 1,1-dioxide derivatives thereof; wherein R.sub.1 is phenyl or substituted phenyl; R.sub.2 is chlorine or bromine; R.sub.3 is hydrogen, alkyl, alkoxy, halogen, or trifluoromethyl; n is 2, 3, or 4; m is 0, 1 or 2, A is CH--R.sub.4, N--R.sub.5 or oxygen, R.sub.4 is hydrogen or alkyl, and R.sub.5 is hydrogen, alkyl, monohydroxyalkyl, phenyl, or substituted phenyl, provided that when m is 0 or 2, A is CH--R.sub.4 ; have useful pharmacological activity.
摘要:
Benzothiazepines having the formula: ##SPC1##Wherein R.sub.1 is phenyl or substituted phenyl wherein the substituent is selected from the group consisting of alkyl, alkoxy, halogen, trifluoromethyl or alkyl ##EQU1## R.sub.2 is chlorine or bromine; and R.sub.5 is hydrogen, alkyl, alkoxy, halogen or trifluoromethyl; and wherein the terms alkyl and alkoxy, in each instance employed, refer to groups having 1 to 6 carbon atoms. These compounds are useful as intermediates in the preparation of the claimed pharmaceutically active compounds of Ser. No. 462,266, filed Apr. 19, 1974, now U.S. Pat. No. 3,895,006.